More recently, RCC has been shown to possess an epithelial to mesenchymal transition (EMT) phenotype and levels of EMT-related factors E-cadherin, Twist1, Vimentin, and β-catenin have been linked to adverse pathologies, increased recurrence, and reduced survival [2, 7]. This evidence concerns the gene CDH1 and renal cell carcinoma.